Introduction: endoscopic ultrasonography (EUS) has already proven useful in the assessment of submucosal lesions, and the staging of gastrointestinal cancer, particularly gastric MALT-type lymphoma. The goal of this paper was EUS staging.
INTRODUCTION
Endoscopic ultrasonography (EUS) has proven useful in the assessment of submucosal lesions (1), the staging of gastrointestinal cancers (2) , and particularly the staging of low-grade gastric MALT (mucosa-associated lymphoid tissue) lymphoma (2) , with sensitivity in the range of 80-95% (3) (4) (5) (6) (7) .
Sensitivity to detect suspicious adenopathies is more variable (70%), and oscillates between 50 and 90% (3-6); however, diagnostic accuracy in the assessment of lymph-node involvement extent might reach 100% with the recent introduction of echo guided puncture.
Response to Helicobacter pylori eradicating therapy may also be predicted (7) (8) (9) (10) (11) . Thus, a lesion extending beyond the submucosa, or in the presence of metastatic adenopathies, will usually not respond to H. pylori eradicating therapy, whereas remission rates reach 95% for lesions involving the mucosa or submucosa (EI1: mucosalsubmucosal T1, N0).
The subject of this paper is EUS staging.
PATIENTS AND METHODS
Twenty-four patients (10 females, 14 males) aged 18 to 82 years, with a mean age of 56 years, and with suspected gastric MALT lymphoma (25 cases) were studied by videoendoscopy and biopsy, and staged according to the TNM classification using EUS with a 7.5 MHz, 20 MHz Radial Olympus, and both radial and linear, 12 and 20 MHz (Fuji SP-701) (2.6 mm) miniprobes introduced through the videoendoscope's working channel (2.8 mm). We are recently using Olympus UM-DP 12-25R and 20-25R, 12 and 20 MHz, MPs with a DPR system. Endoscopy and biopsies were performed using a Fujinon EG-200 FP and EG-400 FP videoendoscope. An informed consent was always required.
MP findings were compared to those of radial EUS (gold standard) and histology, both before and after H. pylori eradication.
Inclusion criteria included: patients with low-grade MALT lymphoma, H. pylori positivity; exclusion criteria included: high-grade MALT lymphoma, IBD, and human immunodeficiency virus positivity.
Nineteen patients were definitely assessed (7 females, 12 males), as five patients were dispensed with when a high-grade, invasive gastric lymphoma (3c) or plasmocytoma (2c) was demonstrated post-hoc, with one of them dying.
The 1997 TNM classification (12) for the staging of gastric adenocarcinoma was used to study every lymphoma's penetration into the gastric wall: T1, mucosal and submucosal invasion; T2, muscularis propria invasion; T3, invasion beyond the muscularis propria and into the serose layer; T4, invasion of adjacent structures (Figs. 1-5).
N0, no adenopathies; N1, regional adenopathies.
Regional metastatic adenopathies were defined as homogeneous, hypoechogenic, rounded nodules greater than 5 mm in size. In no case was an echo guided puncture performed.
Following eradication using triple therapy for 7-14 days, patients were controlled every 1-3-6 months with videoendoscopy and miniprobes.
Out of 19 patients, all were T1 except for two, who were T2, while another female patient had a gastroduodenal T1 MALT lymphoma (13) . In all, 20 cases of MALT lesions in 19 patients, since one patient had both gastric and duodenal involvement. Frequency and sensitivity were analyzed using standard formulas.
RESULTS
Echoendoscopy with EUS and/or MPs correctly identified T stages in 90% of cases (18/20) , and N stages in 40% of cases (8/20) (Table I) . MPs identified T stage (all were T1, except two with T2) in 88% of cases, and N stage in 33% of cases, with results being slightly inferior to those obtained with conventional radial EUS (91 and 45%), and were thus used for follow-up. Adenopathies detected were always greater than 5 mm.
Following eradication, all T1s (EI1) but three (81%) are in full remission and have been followed every 1-3-6 months using MPs with no echographic abnormalities, except for a female patient who had a relapse during follow-up. No complications occurred. 
DISCUSSION
Conventional radial EUS assesses T stage with a precision and sensitivity around 85-90%, and N stage with a sensitivity around 70% (60-90%) (2-7). In our patients it was 90 and 40%, respectively.
Initial layer involvement and the absence of adenopathies directs towards a low-grade MALT lymphoma, whereas massive transwall infiltration and the presence of adenopathies usually suggests a high-grade lymphoma (8) . According to these parameters EUS may predict response to treatment (8) (9) (10) . With early diagnosis and treatment the prognosis of patients with low-grade gastric MALT lymphoma is usually good.
Endoscopic ultrasonography with an MP has a diagnostic accuracy and precise prognostic assessment similar to conventional EUS. Effectively, Lügering et al. (11) studied 39 patients with gastric MALT lymphomas smaller than 4 cm, 15 before treatment and 24 during followup; by comparing conventional EUS to a 12-MHz MP, in the assessment of T stage they obtained 80 versus 86%, and in the assessment of N stage they obtained 60 versus 53%, with differences not reaching statistical significance. During follow-up, when MP findings were normal (15 cases), a subsequent histologic examination confirmed full remission in all patients, while hypoechogenic lesions within the mucosa or submucosa were detected in 9 cases, with only 4 cases receiving histologic confirmation for relapse (44.5%). In our patients, follow-up with an MP demonstrated no echographic abnormalities, which correlated well to negative histologic findings, except in a patient who had relapsing disease. When comparing EUS and MP before eradicating therapy, we obtained 91 versus 88% for T staging, and 45 versus 33% for N staging. Adenopathies identified were always smaller than 1 cm.
Ultrasonographic studies using an MP may be performed during the endoscopic procedure itself -both for diagnosis and follow-up-when a gastric lesion is suspected, which may be biopsied concomitantly. No complications occurred. Conventional EUS requires a re-examination following endoscopy and biopsy. Some times balloon compression makes difficult the study of superficial lesions, whereas MPs are precisely indicated in this type of lesions, particularly high-frequency MPs, which have a very high close-up resolution at the expense of scarce ultrasound penetration.
However, the greatest limitation of conventional EUS is advanced, stenosing lymphomas. In such rare cases, MPs offer a better T staging, but poorer N staging capability (11) .
We think that MPs may be used in the staging of lowgrade gastric MALT-type lymphoma during the endoscopic procedure, and particularly during follow-up, with a high sensitivity similar to that obtained in previous studies with conventional EUS. Its main limitation would be N staging, which may be compensated for by using either multi-frequency or low-frequency/high penetration MPs.
By appropriately selecting patients long-term remission could be a fact approaching 100 versus 80% as reported by some literature review (14) . Recently, Diz-Lois et al. (15) reported on 14 EI1 (MALT involvement only up to the submucosa) patients, with 71% full remissions after eradication, and 100% cures following eradication and chemotherapy in cases not reaching a full remission. In our EI1 cases remission was complete in 81%, with cure in also 100%. Five-year survival is usually above 70% (16, 17) .
While the Italian experience (18, 19) with 76 initial cases reports very successful eradication results as a function of staging (relevant remission for T1N0 stages), with an accuracy of 95%, sensitivity of 89%, and specificity of 97% for EUS in the staging procedure, such is not the case with the German experience (20) . Fischbach et al. (20) , in a multicenter study of 80 cases with several work groups, conclude that EUS staging was only successful in 53% of cases, as EUS underestimates the diagnosis of adenopathies. Similar results have been reported by only one group (21) . These difficulties may improve using echo guided puncture to tell inflammatory from metastatic adenopathies; however, even in such case percentages would not reach 100%, as a recent Japanese paper quotes 94% positives (22) with a 19-G needle.
